Patents Assigned to Celloram Inc.
  • Publication number: 20230132140
    Abstract: The present application discloses a method of treating cancer, including administering to a person suffering from cancer or in remission from cancer, an antigen presenting cell loaded with an immunogenic CD4 T cell activating antigen and a CD8 T cell activating neoantigen specific for the cancer.
    Type: Application
    Filed: September 15, 2022
    Publication date: April 27, 2023
    Applicant: Celloram Inc.
    Inventors: Seunghwan Lim, Tej Kumar Pareek, Liraz Levi, Seong-Jin Kim